Stockreport

Merck, Daiichi lung cancer therapy rejected in U.S. [Seeking Alpha]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Daiichi Sankyo ( OTCPK:DSKYF ) as a late-line option for a certain type of lung cancer. The companies announced Thursday night that the agency issued a so-called compl [Read more]